Cargando…
Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report
BACKGROUND: Ganciclovir is a therapeutic choice for extremely premature infants with severe postnatal cytomegalovirus disease, but little is known about its optimal dose size and dosing interval for them. CASE PRESENTATION: We treated an extremely premature female infant with postnatal cytomegalovir...
Autores principales: | Sunada, Mariko, Kinoshita, Daisuke, Furukawa, Naoko, Kihara, Minako, Nishimura, Akira, Moriuchi, Masako, Moriuchi, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994216/ https://www.ncbi.nlm.nih.gov/pubmed/27550172 http://dx.doi.org/10.1186/s12887-016-0683-x |
Ejemplares similares
-
Purpuric skin lesions possibly associated with acquired cytomegalovirus infection
por: Esaki, Hiroyuki, et al.
Publicado: (2019) -
Ganciclovir penetrates into the cerebrospinal fluid of an infant with congenital cytomegalovirus infection
por: Natale, Fabio, et al.
Publicado: (2015) -
Factors Secreted by Human T Lymphotropic Virus Type I (HTLV-I)–infected Cells Can Enhance or Inhibit Replication of HIV-1 in HTLV-I–uninfected Cells: Implications for In Vivo Coinfection with HTLV-I and HIV-1
por: Moriuchi, Hiroyuki, et al.
Publicado: (1998) -
Cytomegalovirus-associated esophageal ulcer in an immunocompetent infant: When should ganciclovir be administered?
por: Jang, Hyo-Jeong, et al.
Publicado: (2012) -
Ganciclovir/letermovir: Rebound Cytomegalovirus hepatitis, acquired resistance to ganciclovir and nephrotoxicity: case report
Publicado: (2020)